Abstract
Objectives The synovial endothelium targeting peptide (SyETP) CKSTHDRLC has been identified previously and was shown to preferentially localise to synovial xenografts in the human/severe combined immunodeficient (SCID) mouse chimera model of rheumatoid arthritis (RA). The objective of the current work was to generate SyETP-anti-inflammatory-cytokine fusion proteins that would deliver bioactive cytokines specifically to human synovial tissue.
Methods Fusion proteins consisting of human interleukin (IL)-4 linked via a matrix metalloproteinase (MMP)-cleavable sequence to multiple copies of either SyETP or scrambled control peptide were expres
学科代码:风湿病学 关键词:none ,全球精选全文 爱思唯尔医学网, Elseviermed
来源: Annals of The Rheumatic Diseases
来源: Annals of The Rheumatic Diseases
顶一下(0)
- 您可能感兴趣的文章
-